Compile Data Set for Download or QSAR
maximum 50k data
Report error Found 13 Enz. Inhib. hit(s) with all data for entry = 1175
TargetNeprilysin(Human)
Novartis

US Patent
LigandPNGBDBM155343(US9006249, Example 49-2 | US9603819, Example 49-2)
Affinity DataIC50:  0.0300nMAssay Description:The activity of a compound according to the present invention can be assessed by the following in vitro & in vivo methods and/or by the following in ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetNeprilysin(Human)
Novartis

US Patent
LigandPNGBDBM309469((2R,4S)-5-(3′-Chloro-biphenyl-4-yl)-4-[(3-hy...)
Affinity DataIC50:  0.0400nMAssay Description:The activity of a compound according to the present invention can be assessed by the following in vitro & in vivo methods and/or by the following in ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetNeprilysin(Human)
Novartis

US Patent
LigandPNGBDBM155344(US9006249, Example 49-3 | US9603819, Example 49-3)
Affinity DataIC50:  0.300nMAssay Description:The activity of a compound according to the present invention can be assessed by the following in vitro & in vivo methods and/or by the following in ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetNeprilysin(Human)
Novartis

US Patent
LigandPNGBDBM153108(US8993631, 16-5 | US9006249, Example 3-32 | US9603...)
Affinity DataIC50:  1nMAssay Description:The activity of a compound according to the present invention can be assessed by the following in vitro & in vivo methods and/or by the following in ...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetNeprilysin(Human)
Novartis

US Patent
LigandPNGBDBM309463(US9603819, Example 3-60)
Affinity DataIC50:  7.30nMAssay Description:The activity of a compound according to the present invention can be assessed by the following in vitro & in vivo methods and/or by the following in ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetNeprilysin(Human)
Novartis

US Patent
LigandPNGBDBM309468((2R,4S)-5-biphenyl-4-yl-2-methyl-4-[(1H-tetrazole-...)
Affinity DataIC50:  14nMAssay Description:The activity of a compound according to the present invention can be assessed by the following in vitro & in vivo methods and/or by the following in ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetNeprilysin(Human)
Novartis

US Patent
LigandPNGBDBM153116(US8993631, 19 | US9006249, Example 7-1 | US9603819...)
Affinity DataIC50:  93nMAssay Description:The activity of a compound according to the present invention can be assessed by the following in vitro & in vivo methods and/or by the following in ...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetNeprilysin(Human)
Novartis

US Patent
LigandPNGBDBM153117(US8993631, 20 | US9006249, Example 9-1 | US9603819...)
Affinity DataIC50:  142nMAssay Description:The activity of a compound according to the present invention can be assessed by the following in vitro & in vivo methods and/or by the following in ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetNeprilysin(Human)
Novartis

US Patent
LigandPNGBDBM153107(US8993631, 16-3 | US9006249, Example 3-6 | US96038...)
Affinity DataIC50:  250nMAssay Description:The activity of a compound according to the present invention can be assessed by the following in vitro & in vivo methods and/or by the following in ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetNeprilysin(Human)
Novartis

US Patent
LigandPNGBDBM153113(US8993631, 15-1 | US9006249, Example 2-1 | US96038...)
Affinity DataIC50:  267nMAssay Description:The activity of a compound according to the present invention can be assessed by the following in vitro & in vivo methods and/or by the following in ...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetNeprilysin(Human)
Novartis

US Patent
LigandPNGBDBM153112(US8993631, 14-1 | US9006249, Example 1-1 | US96038...)
Affinity DataIC50:  283nMAssay Description:The activity of a compound according to the present invention can be assessed by the following in vitro & in vivo methods and/or by the following in ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetNeprilysin(Human)
Novartis

US Patent
LigandPNGBDBM153114(US8993631, 17 | US9006249, Example 5-1 | US9603819...)
Affinity DataIC50:  350nMAssay Description:The activity of a compound according to the present invention can be assessed by the following in vitro & in vivo methods and/or by the following in ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetNeprilysin(Human)
Novartis

US Patent
LigandPNGBDBM153115(US8993631, 18-1 | US9006249, Example 6-1 | US96038...)
Affinity DataIC50:  450nMAssay Description:The activity of a compound according to the present invention can be assessed by the following in vitro & in vivo methods and/or by the following in ...More data for this Ligand-Target Pair
In DepthDetails US Patent